Drug Discovery
Robot Scientist
“Eve exploits artificial intelligence to learn from early successes in her screens and select compounds that have a high probability of being active against a chosen drug target,”
Eve automates early-stage drug design. The robot system is able to screen over 10,000 compounds per day, and uses a smart screening system based on genetically engineered yeast. This allows Eve to exclude compounds that are toxic to cells and select those that block the action of the parasite protein while leaving any equivalent human protein unharmed.”
You must be logged in to post a comment.